Objectives: Oxygen is a component, which is indispensable for the life. Without oxygen the death is assured. Although, everybody knows this fact a lot of medical acts forgot to take care of it, which are responsible of lot of troubles. Indeed, during the cell respiration the glucose oxidation by oxygen gives carbon dioxide, water and energy. This energy also called ATP is necessary for cellular metabolism.
Introduction: We have identified a marine molecule called extracellular hemoglobin coming from a marine worm, which is able to deliver oxygen in this animal leaving on the intertidal areas on the Atlantic coast in France between the North Sea and Biarritz. This molecule called M101 was developed in the medical device named HEMO2life®. We have showed that this product was very efficient to protect organs before transplantation added to organ preservation solution.
Materials / method: M101 is manufactured under GMP process using Arenicola marina farmed in the Ferme Marine de Noirmoutier. Final product is called HEMO2life and could be used for cells, tissues and organ preservations.
Results: A clinical trial performed on 60 patients waiting kidney grafts showed a delay graft function reduced roughly by tree between the two kidneys harvested on the same donor with and without HEMO2life® and grafted on recipients. In 2018, a first worldwide was realized in France by the Pr. Lantieri to Georges Pompidou hospital in Paris, France. Indeed, it was the first time that a patient received a second graft face. This surgery was realized with HEMO2life and showed a very nice result Furthermore, we have developed dressing incorporating M101 making a product called HEMHealing®.
Conclusion: Hence we showed that M101 can delivered oxygen at different biological levels, cellular, tissues and organs and could be used in different surgical acts in order to conserve biological material once disconnected to vascular circulation as fat cells for breath reconstruction, skin grafts in plastic surgery or organ preservation in order to replace a non functional organ.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
是
请注明名称(个人,公司,学会等等): private funds
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
是
请注明名称(个人,公司,学会等等): founder of HEMARINA
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
是
请注明日期: granted
和审阅情况: Patents
这项工作的完成感谢以下机构的支持: Hemarina